U.S. Markets close in 30 mins
  • S&P 500

    +72.40 (+1.60%)
  • Dow 30

    +685.79 (+2.02%)
  • Nasdaq

    +141.42 (+0.93%)
  • Russell 2000

    +58.42 (+2.72%)
  • Crude Oil

    +1.58 (+2.41%)
  • Gold

    -16.10 (-0.90%)
  • Silver

    +0.06 (+0.27%)

    -0.0018 (-0.1583%)
  • 10-Yr Bond

    +0.0140 (+0.98%)
  • Vix

    -3.07 (-9.87%)

    +0.0023 (+0.1729%)

    +0.3660 (+0.3245%)

    +73.24 (+0.13%)
  • CMC Crypto 200

    +8.83 (+0.61%)
  • FTSE 100

    -39.47 (-0.55%)
  • Nikkei 225

    -182.25 (-0.65%)

Axxess Pharma Diversifies Revenue Stream and Targets US Retailers With New Oral Health Care Line

TORONTO, ON--(Marketwired - May 11, 2016) - Axxess Pharma Inc. (OTC PINK: AXXE) a specialty pharmaceutical and nutritional supplements company, through its wholly owned subsidiary, AllStar Health Brands Inc., is pleased to announce they have expanded and diversified their revenue stream into the high growth, oral health care sector.

The Company will be distributing two oral health care products known as Septicon Mouthwash and Rompe Pecho Syrup.

Septicon Mouthwash is alcohol free, antibacterial and an antiseptic. The oral hygiene product may help prevent and control tooth decay while reducing plaque and tartar. This unique product is also extremely useful with individuals experiencing medical conditions such as diabetes, radiation therapies, systemic diseases such as Sjorgen's syndrome and xerostomia (dry mouth), and low saliva flow due to certain medicinal side effects.

Beyond these conditions, studies by BioMed Research International suggest alcohol free mouthwashes also have a better effect on the gloss, color and hardness of teeth compared to mouthwashes that contain alcohol.

Currently, mouthwash products are experiencing strong global growth as customers realize the short and long-term benefits of oral hygiene. This global growth includes countries such as Saudi Arabia, Pakistan, Israel, China, Ireland and Algeria.

Axxess Pharma's second product is known as Rompe Pecho Syrup and is a cough remedy designed to help in relieving respiratory tract ailments such as the common flu. This special health care product also may quickly improve congestion and cough through decreasing secretions.

Management will be distributing both health care products within the United States with a special focus on targeting big box retailers such as CVS and Super Stop and Shop.

Dr. Daniel Bagi, President of Axxess Pharma, Inc. stated, "Our new line of oral health care products are designed to assist with the needs of those with diabetes and other medical conditions, while being easily accessible as an Over The Counter (OTC) product. Our products also meet the needs of those with no specific medical condition but seek to improve their overall hygiene and health." Dr. Bagi further stated, "We anticipate strong growth of our product line based on our pricing, packaging, performance and overall rising global demand within the oral health care sector."

About Axxess Pharma Inc.:
Axxess Pharma Inc. is a Nevada Corporation operating through its wholly-owned Canadian Subsidiary: Axxess Pharma Canada Inc., headquartered in Toronto. Axxess is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select medicines, nutritional supplements and over the counter remedies all across the Americas. Axxess's goal is to bring additional products to the market and provide new, innovative options for better health spanning areas such as high cholesterol, blood pressure, acute pain, - to optimal health management through improved nutritional supplements.

For more information, please contact Investor Relations at (646) 820-5501.

Safe Harbor Statement

Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.

The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management, as well as assumptions made by any information currently available to the Company or its management. When used in this document, the words "anticipate," "estimate," "expect," "intend," "plans," "projects," and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties.